Based on elevated FPP levels and FPPS gene expression in contrast to unchanged cholesterol levels and HMG-CoA reductase gene expression, a tentative conclusion is that the increase in FPP levels in AD brain may not involve the SCAP/SREBP-2 pathway. Here, HMGCR is linked to Alzheimer disease.